Home » Newsletters » BioWorld

BioWorld

Oct. 4, 1995

View Archived Issues

MICROPROBE SELLS DIAGNOSTICS BUSINESS TO BECTON DICKINSON

OTHER NEWS TO NOTE

ABRUPTLY CLOUDED VISION CLUES IN CLINICIANS TO UNSUSPECTED LUNG TUMOR

GILEAD SCIENCES SUBMITS NEW DRUG APPLICATION FOR VISTIDE

SYNCOR TO DISTRIBUTE NEOPROBE'S RIGS PRODUCTS

BIOMIRA'S TRUQUANT RECOMMENDED FOR APPROVAL

SANDOZ TAPS PHARMACOPEIA'S COMBINATORIAL CHEMISTRY FOR DRUG DISCOVERY

BIOMARKER IDENTIFIED FOR CELL AGING IN VIVO

SCIOS NOVA RE-FOCUSES CLINICAL TRIALS OF AURICULIN TO OLIGURIC ACUTE

NORTH AMERICAN VACCINE SIGNS $50M PACT WITH PASTEUR MERIEUX

BIOTECHNOLOGY STOCKS TAKE A BATH

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...